Suppr超能文献

引流淋巴结和肿瘤微环境中肿瘤特异性CD8 T细胞的功能亚群。

Functional subsets of tumor-specific CD8 T cells in draining lymph nodes and tumor microenvironment.

作者信息

Huang Qizhao, Xu Lifan, Ye Lilin

机构信息

Institute of Immunological Innovation and Translation, Chongqing Medical University, Chongqing, China; Guangdong Provincial Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.

Institute of Immunology, Third Military Medical University, Chongqing, China; National Key Laboratory of Trauma and Chemical Poisoning, Third Military Medical University, Chongqing, China.

出版信息

Curr Opin Immunol. 2025 Feb;92:102506. doi: 10.1016/j.coi.2024.102506. Epub 2024 Nov 26.

Abstract

Accumulating evidence demonstrates that tumor-specific CD8 T cells in tumor-draining lymph nodes (TdLNs) act as an upstream reservoir of exhausted subsets within tumor microenvironment (TME). This reservoir primarily consists of progenitor exhausted CD8 T (T) cells and newly defined tumor-specific memory subsets (T). We propose that these two subsets work together to mediate the antitumor effects of PD-1/PD-L1 immune checkpoint blockade (ICB) in a spatiotemporal manner. Although PD-1/PD-L1 ICB monotherapy drives the proliferation and further differentiation of these subsets, it does not alter the programmed differentiation trajectory from T cells to T cells, ultimately leading to the development of terminally exhausted CD8 T cells. This phenomenon may partly explaining the frequent relapse in patients following initial ICB therapy. In this review, we focus on the phenotypic and functional heterogeneity of tumor-specific CD8 T cells in both TdLNs and the TME and discuss the implications of these studies for ICB. Our insights aim to illuminate new strategies for advancing tumor immunotherapies.

摘要

越来越多的证据表明,肿瘤引流淋巴结(TdLNs)中的肿瘤特异性CD8 T细胞是肿瘤微环境(TME)中耗竭亚群的上游储存库。这个储存库主要由祖细胞耗竭性CD8 T(T)细胞和新定义的肿瘤特异性记忆亚群(T)组成。我们提出,这两个亚群共同发挥作用,以时空方式介导PD-1/PD-L1免疫检查点阻断(ICB)的抗肿瘤作用。虽然PD-1/PD-L1 ICB单药治疗驱动这些亚群的增殖和进一步分化,但它不会改变从T细胞到T细胞的程序性分化轨迹,最终导致终末耗竭性CD8 T细胞的产生。这种现象可能部分解释了初始ICB治疗后患者频繁复发的原因。在这篇综述中,我们重点关注TdLNs和TME中肿瘤特异性CD8 T细胞的表型和功能异质性,并讨论这些研究对ICB的意义。我们的见解旨在阐明推进肿瘤免疫治疗的新策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验